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Abstract

Keywords

The relationship between thyroid dysfunction and postpartum depression has been
investigated for quite some time now, but no consensus has been reached regarding the need for
screening for thyroid function during pregnancy. This paper aims to investigate whether thyroid
hormone screening in pregnancy might contribute to the diagnosis of postpartum depression.
Depression was assessed using the Edinburgh Postnatal Depression Scale (EPDS) - one of the
most widely used measures in detecting postpartum depression and anxiety. Thyroid function was
measured using the commonly recommended thyroid laboratory tests.
A structured questionnaire was given to 61 patients closely monitored during their pregnancy
and at least one year after giving birth, including for thyroid and depression disorders. The
questionnaire was completed anonymously online by the patients and had three sections: one
containing the EPDS questions, one assessing thyroid function, and a demographic section.
The interdependency between thyroid and depression was analyzed in SPSS using the Pearson
chi-square test of independence. The results show no statistically significant relationship between
thyroid dysfunction and depression. In other words, women suffering from thyroid dysfunctions
have no greater rate of depression compared to women without thyroid dysfunction. As a result, it
screening for thyroid disorders during pregnancy may not provide relevant information for
detecting postnatal depression.


Postpartum depression (PPD), thyroid dysfunction, Edinburgh Postnatal Depression
Scale (EDPS)

Highlights

 This study found no difference in postpartumdepression for women with thyroid
dysfunction compared to women without thyroid dysfunction.
 The study pinpoints the need for appropriate and constant assessment of postpartum
depression in Romania and the creation of an appropriate medical structure to identify

and mitigate the risks of postpartum depression.
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Introduction
Postpartum depression (PPD) is defined as a nonpsychotic depressive episode that can last from one month
up to one year after birth (1). If left undiagnosed, the
disorder may have negative consequences, on both the
mother and the child. It is estimated that PPD affects 10 to
15% of new mothers (2, 3). Mothers’ postpartum mood
disturbance may lead to an increased risk of affecting the
child’s cognitive capacity, social skills, and long-term
affections. (4). However, less than half of postnatal
depression cases are detected through routine clinical
practice (5).
Thyroid disorders are among the most common
endocrine pathologies during pregnancy and the
postpartum period. The prevalence of thyroid dysfunction
in postpartum ranges between 1.1 % and 16.7 % across
the country (6). Studies have shown that maternal thyroid
autoimmunity was associated with postpartum depression
(7). The majority of women predisposed to develop
postpartum thyroiditis have subclinical thyroid
autoimmune disease manifestations early in the pregnancy
(e.g. hyperemesis gravidorum). At the postpartum visit,
thyroiditis does not necessarily manifest clinically and
thus it is important that physicians be aware of the risks of
thyroid disorders.
Nevertheless, in everyday practice there are
insufficient data to recommend universal screening for
thyroid in pregnancy, and, in the absence of clinical
symptoms, treatment is unnecessary (8, 9).
In Romania, screening for neonatal hypothyroidism
has been performed at birth since 1979. The incidence of
hypothyroidism is 1 in 3,409 new-born babies (10).
Currently, several postpartum screening tools are used
for identifying depression, such as Hamilton Depression
Rating Scale – HDRS, developed by Hamilton in 1960;
Cronhom – Ottoson scale, also introduced in 1960;
Melancholia Scale – introduced by Bech and Rafaelse in
1980; Montgomery – Asberg Depression Rating Scale –
MADRS, developed in 1976, as well others, many based
on the Hamilton scale.
The Edinburgh Postnatal Depression Scale (EDPS)
was developed by Cox and collaborators in 1987 (11).
The aim of the scale was to identify women suffering
from postpartum depression. The scale was initially tested
in Edinburgh and Livingston and consisted of 10
questions with responses on a Likert scale (see Figure 1).
Studies conducted on the scale’s validity showed that
almost 92 percent of women suffering from postpartum
depression are correctly diagnosed using the EDPS.
However, the scale is used only as a screening tool and
not as a diagnostic tool in the public health system, i.e., a
diagnosis of depression should be made only by
specialized healthcare providers. Nevertheless, the EPDS
scale is a useful tool for providing preliminary
information.
The objective of this article is to test whether there is a
relationship between thyroid dysfunction (diagnosed
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before, during, or after pregnancy) and postnatal
depression.
The analysis is performed based on questionnaires
completed by mothers one year or more after birth,
retrospectively assessing their postpartum depression at 3
months after birth, based on the Edinburgh Scale and also
answering questions related to thyroid disorders. The aim
is to assess if patients known for thyroid pathologies or
those who later discovered their thyroid problems are
more likely to suffer from postpartum depression, thereby
establishing a link between the two disorders. If so, the
need for screening for thyroid disorders during pregnancy
might be justified.

Materials and Methods
We performed a structured questionnaire-based study
on 61 women at least one year after birth, our goal being
to assess the relationship between thyroid dysfunction and
postpartum depression.
The two variables - thyroid function and postpartum
depression - were measured as follows: the first used T3,
T4, and TSH laboratory tests; the second, depression, was
assessed using the Edinburgh Postnatal Depression Scale
– EDPS.
Women were tested during pregnancy for thyroid
function (T3, T4 and TSH) and monitored for at least one
year after birth (including thyroid dysfunction and
psychiatric disorders). We included only women with
full-term birth; we excluded patients with high risk
pregnancies: prematurity, malformations, etc. that might
lead to depression. Patients with thyroid carcinoma or
undergoing hormonal replacement therapy were excluded
as well.
The questionnaire was distributed to 65 women in
February 2017, and 61 valid anonymous surveys were
introduced in the data base. Consent forms for the use of
personal data in this study were signed beforehand.
The questionnaire was structured in three sections: one
containing socio-demographic questions, one assessing
the thyroid function, and one regarding self-assessed wellbeing based on Edinburg depression Scale – completed
one year or more after birth regarding their state at 3
months after giving birth.
Regarding demographic aspects, respondents were
mainly from Bucharest and neighboring counties. At the
time of child birth, the youngest mother was 21 and the
oldest 41 years. The average mother’s age at delivery was
30.6 years – close to the median age of 30 years
(indicating that half of the mothers are 30 years old or
younger and the other half are 30 years old or more).
The section related to thyroid gland functioning was
summarized in the following three variables:

Postpartum depression and screening for thyroid dysfunction
 Variable 1 – a variable showing if the patient had or
did not have thyroid issues before pregnancy;
 Variable 2 – a variable showing if the patient
underwent or did not undergo treatment for the thyroid
before pregnancy;
 Variable 3 – a variable showing if the patient
underwent or did not undergo treatment for the thyroid
during pregnancy or immediately after (in the first
year after giving birth).
The last of the three sections was based on the
Edinburgh Postnatal Depression Scale (EPDS). This test
to evaluate postpartum depression consists of ten
questions answered by the mother. Responses have four
possibilities, scored from 0 to 3, with overall scores
linked to the severity of the symptoms. The cut-off scores
for depression have typically ranged from 9 to 13 points.
Based on the score, the patients in our sample were
included in one of the two categories: With or Without
depression, with 10 points serving as the cut-off point).
Q1 Was able to laugh and see the
funny side of things

No of
Percentage
pacients

As much as I always could

34

55.7%

Not quite so much now
Definitely not so much now
Not at all

17
9
1

27.9%
14.8%
1.6%

Q2 Have looked forward with enjoyment
No of
Percentage
to things
pacients
As much as I ever did
44
72.1%
Rather less than I used to
13
21.3%
Definitely less than I used to
4
6.6%
Hardly at all
0
0.0%
Q3* Have blamed yourself
unnecessarily when things went wrong
Yes, most of the time
Yes, some of the time
Not very often
No, never

No of
Percentage
pacients
16
26.2%
21
34.4%
10
16.4%
14
23.0%

The EPDS results were cross-tabulated against the
three thyroid-related variables. The Pearson Chi
squared test was used to test whether depression (Yes/
No based on the EPDS scale) and thyroid dysfunction
(hypo- or hyperthyroidism - before or after pregnancy)
are associated. This test was chosen as each of
the two/paired variables are measured on a categorical
or ordinal scale, and the two variables consist of two or
more categorical independent groups. Data analysis
was performed using SPSS Software.

Results
The assessment of depression based on the ten EPDS
questions is summarized in Figure 1. Each question is
separately presented as well as an overall distribution of
responses.
Responses to questions 1, 2, and 4 are scored 0, 1, 2,
or 3 according to increased severity of the symptom. The
rest of the questions are marked with an asterisk (*)
meaning that they were reverse scored (i.e. 3, 2, 1, and 0).
Q6* Things have been getting on top of me
Yes, most of the time I haven’t been able to
cope at all
Yes, sometimes I haven’t been coping as
well as usual
No, most of the time I have coped quite well
No, have been coping as well as ever
Q7* Have been so unhappy that I have had
difficulty sleeping
Yes, most of the time
Yes, sometimes
Not very often
No, not at all
Q8* Have felt sad or miserable
Yes, most of the time
Yes, quite often
Not very often
No, not at all

No of
Percentage
pacients
18

25.0%

18
18
18

25.0%
25.0%
25.0%

No of
Percentage
pacients
5
8.2%
8
13.1%
13
21.3%
35
57.4%
No of
Percentage
pacients
4
6.6%
8
13.1%
18
29.5%
31
50.8%

Q4 Have been anxious or worried for no
No of
Percentage
good reason
pacients
No, not at all
20
32.8%
Hardly ever
18
29.5%
Yes, sometimes
19
31.1%
Yes, very often
4
6.6%

Q9* Have been so unhappy that I have been
No of
Percentage
crying
pacients
Yes, most of the time
5
8.2%
Yes, quite often
6
9.8%
Only occasionally
15
24.6%
No, never
35
57.4%

Q5* Have felt scared or panicky for no
very good reason
Yes, quite a lot
Yes, sometimes
No, not much
No, not at all

Q10* The thought of harming myself has
occurred to me
Yes, quite often
Sometimes
Hardly ever
Never

No of
Percentage
pacients
5
8.2%
12
19.7%
15
24.6%
29
47.5%

No of
Percentage
pacients
1
1.6%
1
1.6%
4
6.6%
55
90.2%

Figure 1. Assessing depression - distribution of answers to the EPDS questions. Question 10 is important due
to signaling the potential suicidal behavior. The data show that two out of the 61 patients often thought about
harming themselves. The total score is determined by summing up the scores for each of the 10 items. The
score distribution is presented in Figure 2.
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to eight with thyroid disorders who underwent treatment
during or after pregnancy.
We cross-tabulated these two variables to assess their
interdependency, with results presented in Figure 4. None
of the three analyses were significant. Consequently,
these two variables, postpartum depression and thyroid
disorder, occurred independently of one another.
Figure 4. SPSS Results of Pearson chi-square test of
independence
Figure 2. EPDS score distribution for the
group of patients
According to the literature, the cut-off score is
between 9-13 – higher values signaling the possibility of
post- partum depression. In our sample, a score of 10 was
considered the cut-off score, thus erring on the side of
caution. The chart below shows that, although most of the
patients’ scores are on the lower side of the scale, 38%
scored above 10, indicating symptoms of postpartum
depression (see Figure 3).

EDS _Depression_Yes/No_3 months * before pregnancy
thyroid problems? Cross-tabulation
Before pregnancy thyroid
problems?
EDS_Depression No
_3mo*
Yes
Total

Total

No

Yes

Don't know

29

4

5

38

17

3

3

23

46

7

8

61

Chi-Square Tests
Value

df

Pearson Chi-Square

.090a

2

Asymp. Sig.
(2-sided)
.956

Likelihood Ratio

.089

2

.956

Linear-by-Linear
Association

.000

1

.985

No. of Valid Cases

61

Figure 3. The postpartum depression risk structure
of patients
Responses to questions assessing thyroid disorders
before, during, or after pregnancy are summarized in
Table 1.

EDS _Depression_3 months * treatment before pregnancy
Cross-tabulation
Thyroid treatment before
pregnancy
Total

Table 1. Summary of thyroid disorder-related
questions
No

Yes

Don’t Know/
Don’t answer

Variable 1: thyroid issues 75.4% 11.5%
before pregnancy

13.1%

Variable 2: treatment for 85.2% 11.5%
thyroid before pregnancy

3.3%

Variable 3: treatment for 85.2% 13.1%
thyroid during pregnancy
or immediately after (in
the first year after birth)

1.6%

Of the 61 mothers, only seven had had thyroid-related
medical issues before pregnancy and consequently
underwent appropriate treatment. The number increased
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Don't know
Yes
/Not sure

No
EDS_Depression
_3 mo*
Total

No

33

4

1

38

Yes

19

3

1

23

52

7

2

61

Chi-Square Tests
Value

df

Asymp. Sig.
(2-sided)

Pearson Chi-Square

.238a

2

.888

Likelihood Ratio

.233

2

.890

No. of Valid Cases

61
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EDS _Depression_3 months * Treatment pregnancy or after
Cross-tabulation

EDS _Depression
_3 mo
Total

No
Yes

Treatment pregnancy
+ after
0
1
9
33
4
1
19
4
0
52
8
1

Total
38
23
61

Chi-Square Tests
Value

df

Asymp. Sig. (2-sided)

Pearson Chi-Square

1.150a

2

.563

Likelihood Ratio

1.476

2

.478

No. of Valid Cases

61

Discussion
The results demonstrate the complexity of postpartum
depression. From the total of 61 women, 23 had a score of
10 or more out of a possible 30 points. In other words,
38% of the patients presented signs ofpostpartum
depression three months after giving birth. Moreover, the
last question in the EPDS scale identified two patients
who exhibited suicidal risks.
In terms of thyroid disorders, all patients were
monitored during pregnancy. Seven (11.5%) had had prepregnancy thyroid disorders. One patient was diagnosed
and treated for thyroid disorders during pregnancy and
displayed no signs of depression.
From the seven patients diagnosed with pre-pregnancy
disorders, three had an EPDS score indicating depression
signs, and four were not affected by postpartum
depression.
Although the interaction mechanism between thyroid
dysfunctions and psychological disorders is not fully
understood, clinical investigations have recognized the
interdependency between the two disorders (7). The
association between thyroid function and postpartum
mood disorders was seen in Greek women, where lower
levels of FT3 and FT4 serum were linked to increased
mood disturbances in the first postpartum week (12).
Our aim was to identify signs of interdependency
between thyroid dysfunctions before or during pregnancy
or after giving birth and postpartum depression measured
by the Edinburgh Postnatal Depression Scale (EPDS).
However, our data indicate no relationship between
thyroid disorder and postpartum depression, as indicated
by the Chi Square test.
These results are similar to other research works.
Iseme et al. showed no association between depression

and thyroid autoantibodies, based on a group of 2,049
subjects (13). Moreover, treatment with thyroxine
administered to thyroid antibody positive women showed
no impact on reducing the incidence of postpartum
depression (14). Rather, postpartum depression may be
more associated with other factors, including
psychosocial stressors, previous psychiatric history,
complications during pregnancy, or the delivery process
itself (15, 16).
The study has limitations, as it was performed on a
relatively small group of 61 patients, and the number of
patients diagnosed with thyroid disorders was even
smaller (seven patients with existing disorders before
pregnancy plus one person diagnosed with thyroid
disorder during pregnancy). Moreover, patients were
predominantly from Bucharest or nearby Ilfov county
(65.6 percent of the overall number), the rest being from
other counties. The geographic distribution of postpartum
depression is fairly similar to the total distribution. In
terms of thyroid disorder, of the seven patients diagnosed
before pregnancy, four were from Bucharest, one from
Ilfov, and two from other counties. The size of the group
did not allow identification of endemic regions for thyroid
disorders (17-19).
Another limitation of the study could be the
retrospective assessment of depression using the EPDS
questions. Specifically, patients were asked to evaluate
their depression at three months after birth, but the EPDS
questions were answered one year after birth. Additional
data were not available as to whether patients had
received any psychological counselling during or after
pregnancy (20, 21).

Conclusions
The relationship between postpartum depression
(measured on the EPDS scale, three months after birth)
and thyroid dysfunctions (discovered and treated before
pregnancy or during pregnancy) was investigated and
statistically tested in order to assess any relationship
between these variables.
This study found no relationship between
postpartuem depression and thyroid dysfunction. Thus,
thyroid screening during pregnancy may not be useful.
Nevertheless, the study shows a percentage of women
suffering from postpartum depression (an estimate of
38%), exceeding the 10 to 15 percent reported in other
studies. At the same time, postpartum depression is not
regularly screened for in Romania. The study identifies
the possible need for appropriate and constant assessment
of postpartum depression and the establishment of an
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appropriate medical structure to identify and mitigate the
risks of postpartum depression.
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